17694 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
12:33 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1264 | Overweight | $48.00→ $53.00+10.4% |
|
Aug 07
12:33 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★★★☆☆ #1980 | Overweight | $26.00→ $33.00+26.9% |
|
Aug 07
12:33 UTC
|
CART
Maplebear
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1884 | Overweight | $56.00→ $63.00+12.5% |
|
Aug 07
12:33 UTC
|
CARG
CarGurus
|
◎ Target | Marvin Fong ★★☆☆☆ #2513 | Buy | $40.00→ $41.00+2.5% |
|
Aug 07
12:33 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Mitchell S. Kapoor not yet tracked | Neutral | $50.00→ $60.00+20.0% |
|
Aug 07
12:33 UTC
|
BLNK
Blink Charging
|
◎ Target | Sameer Joshi ★★☆☆☆ #2524 | Buy | $2.50 |
|
Aug 07
12:33 UTC
|
BATRK
Atlanta Braves
|
◎ Target | Barton Crockett ★★★★☆ #612 | Buy | $75.00→ $73.00-2.7% |
|
Aug 07
12:33 UTC
|
AVTX
Avalo Therapeutics
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $35.00→ $30.00-14.3% |
|
Aug 07
12:33 UTC
|
ATI
ATI
|
◎ Target | Andre Madrid ★★★☆☆ #1378 | Buy | $180.00→ $270.00+50.0% |
|
Aug 07
12:33 UTC
|
ASTH
Astrana Health
|
◎ Target | Andrew Mok not yet tracked | Overweight | $50.00→ $53.00+6.0% |
|
Aug 07
12:33 UTC
|
AIZ
Assurant
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $310.00→ $325.00+4.8% |
|
Aug 07
12:33 UTC
|
AIG
American International Group
|
◎ Target | Alex Scott ★★★★☆ #837 | Equal Weight | $80.00→ $81.00+1.2% |
|
Aug 07
12:33 UTC
|
ABNB
Airbnb
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1884 | Neutral | $140.00→ $160.00+14.3% |
|
Aug 07
12:33 UTC
|
AAOI
Applied Optoelectronics
|
◎ Target | Ryan Koontz ★☆☆☆☆ #2852 | Buy | $220.00→ $190.00-13.6% |
|
Aug 07
10:33 UTC
|
WPP
WPP
|
◎ Target | firm only | Neutral | GBX 350→ GBX 390+11.4% |
|
Aug 07
10:33 UTC
|
WIZZ
Wizz Air
|
◎ Target | firm only | Neutral | GBX 1,200→ GBX 1,150-4.2% |
|
Aug 07
10:33 UTC
|
TPK
Travis Perkins
|
◎ Target | firm only | Overweight | GBX 630→ GBX 710+12.7% |
|
Aug 07
10:33 UTC
|
SYNT
Synthomer
|
◎ Target | firm only | Hold | GBX 100→ GBX 110+10.0% |
|
Aug 07
10:33 UTC
|
STJ
St. James's Place
|
◎ Target | firm only | Buy | GBX 1,800→ GBX 1,945+8.1% |
|
Aug 07
10:33 UTC
|
SRP
Serco Group
|
◎ Target | firm only | Buy | GBX 371→ GBX 372+0.3% |
|
Aug 07
10:33 UTC
|
SBRY
J Sainsbury
|
◎ Target | firm only | Neutral | GBX 330→ GBX 346+4.8% |
|
Aug 07
10:33 UTC
|
QLT
Quilter
|
◎ Target | firm only | Buy | GBX 215→ GBX 220+2.3% |
|
Aug 07
10:33 UTC
|
LSEG
London Stock Exchange Group
|
◎ Target | firm only | Buy | £129→ £127-1.6% |
|
Aug 07
10:33 UTC
|
HSX
Hiscox
|
◎ Target | firm only | Buy | GBX 1,900→ GBX 2,150+13.2% |
|
Aug 07
10:33 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,380→ GBX 1,450+5.1% |
|
Aug 07
10:33 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 750→ GBX 740-1.3% |
|
Aug 07
10:33 UTC
|
EZJ
easyJet
|
◎ Target | firm only | Neutral | GBX 360→ GBX 715+98.6% |
|
Aug 07
10:33 UTC
|
ADM
Admiral Group
|
◎ Target | firm only | Buy | GBX 4,243→ GBX 4,516+6.4% |
|
Aug 07
10:33 UTC
|
ADM
Admiral Group
|
◎ Target | firm only | Buy | GBX 3,800→ GBX 4,200+10.5% |
|
Aug 07
00:32 UTC
|
ZVRA
Zevra Therapeutics
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $25.00→ $28.00+12.0% |
|
Aug 07
00:32 UTC
|
ZIP
ZipRecruiter
|
◎ Target | Eric Sheridan ★★★☆☆ #1127 | Neutral | $3.50→ $5.00+42.9% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Ronald Josey ★★☆☆☆ #2312 | Buy | $68.00→ $52.00-23.5% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Brad Erickson ★★☆☆☆ #2187 | Outperform | $70.00→ $55.00-21.4% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Maria Ripps ★★★★★ #115 | Hold | $52.00→ $40.00-23.1% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1884 | Neutral | $34.00→ $32.00-5.9% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Tom White ★★★☆☆ #1872 | Buy | $60.00→ $50.00-16.7% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Shyam Patil ★★★☆☆ #968 | Neutral | $50.00→ $38.00-24.0% |
|
Aug 07
00:32 UTC
|
ZG
Zillow Group
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $110.00→ $80.00-27.3% |
|
Aug 07
00:32 UTC
|
ZBH
Zimmer Biomet
|
◎ Target | Rick Wise ★★★★★ #227 | Buy | $105.00→ $110.00+4.8% |
|
Aug 07
00:32 UTC
|
ZBH
Zimmer Biomet
|
◎ Target | Shagun Singh not yet tracked | Outperform | $101.00→ $110.00+8.9% |
|
Aug 07
00:32 UTC
|
ZBH
Zimmer Biomet
|
◎ Target | Lee Hambright ★★★☆☆ #1680 | Market Perform | $91.00→ $93.00+2.2% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Andrew Harte ★★★☆☆ #2089 | Buy | $90.00→ $100.00+11.1% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Bryan C. Bergin not yet tracked | Buy | $101.00→ $105.00+4.0% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Bill Carcache not yet tracked | Overweight | $100.00→ $105.00+5.0% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Timothy Chiodo ★★★★☆ #535 | Buy | $92.00→ $98.00+6.5% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Andrew Schmidt not yet tracked | Overweight | $105.00→ $108.00+2.9% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Daniel R. Perlin not yet tracked | Outperform | $93.00→ $95.00+2.2% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Mayank Tandon ★★★★☆ #854 | Buy | $95.00→ $100.00+5.3% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | James Friedman ★★★☆☆ #1904 | Positive | $90.00→ $100.00+11.1% |
|
Aug 07
00:32 UTC
|
XYZ
Block
|
◎ Target | Vasundhara Govil ★★★☆☆ #1651 | Outperform | $90.00→ $100.00+11.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.